- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
- Contact Us
SARS-CoV-2 (2019-nCoV) Inhibitor Screening Kit (CAT#: Vinh-Wyb041)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-Wyb041 |
|
For Research Use Only. We do not provide services or products directly for patients.
- Product Overview
- The SARS-CoV-2 (2019-nCoV) Inhibitor Screening Kit is designed to facilitate the identification and characterization of SARS-CoV-2 inhibitors. The kit contains a SARS-CoV-2 S protein RBD protein, a biotinylated Human ACE2 protein, an SARS-CoV-2 inhibitor (as method verified Reference), and Streptavidin-HRP reagent.
- Target
- SARS-CoV-2
- Storage
- Store at -70°C.
- Introduction
- 2019 novel coronavirus; SARS-CoV-2; 2019 Wuhan virus pneumonia; Coronaviridae
Related products
Online Inquiry
For Research Use Only. We do not provide services or products directly for patients.
For Research Use Only. We do not provide services or products directly for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.